Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more ...

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based ...

VANCOUVER, BC, CANADA, February 26, 2026 / EINPresswire.com / — ARC Medical Inc. (“ARC”), a leader in surgical adhesion prevention innovation, plans to participate in the following events during the ...

Millions of people struggle to become pregnant in the U.S. And in 2024, fertility rates reached a new low, according to CDC ...

A 'loving and caring' son tragically took his own life after a decade of struggles with his mental health, an inquest has heard. Tyran Jones was just 30 years old when he was found unresponsive at his ...

Brazilian wellness influencer Gabriela Martins Santos de Moura was reportedly in a coma for eight days before she died at age ...

FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --ATLANTA, Feb.

Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.

New treatments for male infertility could widen therapeutic options and possibly shift the treatment burden from women.

President Trump spoke for nearly two hours to a joint session of Congress. President Trump delivered the first State of the ...

Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment --ATLANTA, (GLOBE ...

Live Science spoke with a bioethicist and sociologist about emerging genomic technologies, including those that enable ...